Clinical trial
Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute…
NCT00422565 · Seung-Jung Park, Other · Terminated
Key facts
| NCT number | NCT00422565 |
|---|---|
| Title | Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients |
| Official title | Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients |
| Acronym | ZEST-AMI |
| Lead sponsor | Seung-Jung Park, Other |
| Collaborators | Cordis US Corp. Industry CardioVascular Research Foundation, Korea |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Device |
| Interventions | Endeavor, Medtronic, Cypher, Cordis, Taxus Liberte, Boston Scientific |
| Enrollment | 328 |
| Start date | Oct 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Jan 17, 2007 |
| Last update posted | Dec 7, 2022 |
| Countries | South Korea |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: